U.S. markets closed
  • S&P Futures

    4,306.50
    -1.25 (-0.03%)
     
  • Dow Futures

    34,116.00
    -2.00 (-0.01%)
     
  • Nasdaq Futures

    13,647.50
    -10.75 (-0.08%)
     
  • Russell 2000 Futures

    2,023.50
    +0.20 (+0.01%)
     
  • Crude Oil

    86.71
    +0.18 (+0.21%)
     
  • Gold

    1,790.00
    +0.30 (+0.02%)
     
  • Silver

    20.08
    -0.00 (-0.02%)
     
  • EUR/USD

    1.0174
    +0.0003 (+0.03%)
     
  • 10-Yr Bond

    2.8240
    +0.0330 (+1.18%)
     
  • Vix

    19.69
    -0.26 (-1.30%)
     
  • GBP/USD

    1.2108
    +0.0014 (+0.11%)
     
  • USD/JPY

    134.1700
    -0.0450 (-0.03%)
     
  • BTC-USD

    24,012.31
    -174.63 (-0.72%)
     
  • CMC Crypto 200

    571.28
    -0.64 (-0.11%)
     
  • FTSE 100

    7,536.06
    +26.91 (+0.36%)
     
  • Nikkei 225

    29,097.52
    +228.61 (+0.79%)
     

Novavax says U.S. FDA clears COVID vaccine doses for release

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

July 19 (Reuters) - Vaccine maker Novavax on Tuesday said that the U.S. Food and Drug Administration had cleared a lot of its COVID vaccine for release in the United States, and it plans to ship doses to be distributed by the U.S. government in the coming days.

The FDA authorized the vaccine last week, but the manufactured doses were still awaiting quality testing before they could be released.

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted unanimously to recommend use of the vaccine, and rollout of the shots can begin once the agency's director signs off on that recommendation. (Reporting by Michael Erman; Editing by Mark Porter)